MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jac/dkaf198

Медицинская библиотека · The Journal of antimicrobial chemotherapy · 2025

Indolocarbazoles as host-directed therapeutics against intracellular infections by methicillin-resistant Staphylococcus aureus.

van den Biggelaar Robin H G A, Erdkamp David, de Visser Adriëtte W, van den Eeden Susan J F, Saris Anno

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND

OBJECTIVES

Methicillin-resistant Staphylococcus aureus (MRSA) is a principal contributor to mortality and morbidity attributable to antimicrobial resistance. Many MRSA strains are able to invade host cells, thereby further evading antibiotic treatment. Previously, indolocarbazole GW296115X was identified as a hit compound with host-directed activity against intracellular MRSA. This study evaluates the efficacy and selectivity of indolocarbazoles as potential host-directed therapy against intracellular MRSA. Furthermore, we assessed the interaction between indolocarbazoles and standard-of-care antibiotics.

METHODS

Bioluminescent luxBADCE-expressing MRSA was used to evaluate antimicrobial activity in planktonic cultures and HeLa cell intracellular infection models. Drug safety was assessed through lactate dehydrogenase (LDH) release and WST-1 cytotoxicity assays. The interaction between selected indolocarbazoles in combination with vancomycin or daptomycin was determined based on the Bliss independence model.

RESULTS

Indolocarbazoles GW296115X, staurosporine aglycone, CDK4 inhibitor and SB-218078 showed activity against intracellular MRSA with SB-218078 demonstrating the best potency. None of the effective compounds impaired host cell viability, although host cell metabolic activity was affected to various extents. Combining SB-218078 or GW296115X with vancomycin or daptomycin synergistically eradicated both intracellular and extracellular MRSA.

CONCLUSIONS

Indolocarbazoles, particularly GW296115X and SB-218078, enhance standard antibiotic efficacy against invasive MRSA and offer potential for host-directed therapy.

Для цитирования: van den Biggelaar Robin H G A, Erdkamp David, de Visser Adriëtte W, van den Eeden Susan J F, Saris Anno. Indolocarbazoles as host-directed therapeutics against intracellular infections by methicillin-resistant Staphylococcus aureus.. The Journal of antimicrobial chemotherapy. 2025. DOI: 10.1093/jac/dkaf198.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.